Rajagopal Ramesh to Antineoplastic Agents
This is a "connection" page, showing publications Rajagopal Ramesh has written about Antineoplastic Agents.
Connection Strength
6.318
-
Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Lett. 2023 04 01; 558:216093.
Score: 0.571
-
Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs. Cancer Lett. 2020 08 28; 486:18-28.
Score: 0.472
-
Tumor-Targeted Dendrimer Nanoparticles for Combinatorial Delivery of siRNA and Chemotherapy for Cancer Treatment. Methods Mol Biol. 2020; 2059:167-189.
Score: 0.459
-
Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment. Methods Mol Biol. 2019; 1974:265-290.
Score: 0.429
-
Exosomes as Theranostics for Lung Cancer. Adv Cancer Res. 2018; 139:1-33.
Score: 0.400
-
Recent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery. Adv Cancer Res. 2018; 137:115-170.
Score: 0.398
-
Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems. Drug Dev Ind Pharm. 2017 Sep; 43(9):1391-1401.
Score: 0.383
-
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy. Mar Drugs. 2017 Mar 27; 15(4).
Score: 0.379
-
Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells. Sci Rep. 2016 12 12; 6:38541.
Score: 0.372
-
Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. J Biomed Nanotechnol. 2016 Jun; 12(6):1159-73.
Score: 0.358
-
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer. Cancer Gene Ther. 2015 Dec; 22(12):581-90.
Score: 0.343
-
Nanoparticle-based cisplatin therapy for cancer. Ther Deliv. 2015 Feb; 6(2):115-9.
Score: 0.327
-
EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage. Int J Nanomedicine. 2014; 9:3825-39.
Score: 0.316
-
Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer. AAPS PharmSciTech. 2014 Jun; 15(3):709-21.
Score: 0.306
-
Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb; 4(2):291-304.
Score: 0.163
-
Identification of SMARCAL1 as a molecular target for small cell lung cancer treatment. Cancer Lett. 2024 Jun 28; 592:216932.
Score: 0.155
-
Therapeutic approaches targeting molecular signaling pathways common to diabetes, lung diseases and cancer. Adv Drug Deliv Rev. 2021 11; 178:113918.
Score: 0.128
-
Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment. Nanomedicine. 2018 02; 14(2):373-384.
Score: 0.099
-
HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells. Sci Rep. 2017 08 30; 7(1):9694.
Score: 0.098
-
Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells. Mol Pharm. 2014 Aug 04; 11(8):2720-33.
Score: 0.078
-
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). Int J Oncol. 2007 Nov; 31(5):985-1007.
Score: 0.049
-
Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin Cancer Res. 2002 Sep; 8(9):2963-9.
Score: 0.035